Melanocytic nevus screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]

Overview

Presence of several melanocytic nevi is a strong risk factor for melanoma. Whole body nevus count can help in stratifying the high risk patients prone to developing malignant lesions.

Screening

Presence of several melanocytic nevi is a strong risk factor for melanoma.
In case of presence of numerous melanocytic nevi, one may perform whole body nevus count to identify at-risk patients.^[1]
Two methods to count the nevus are used, whole body nevus count or the site-specific count.^[2]

References

↑ Fariñas-Alvarez C, Ródenas JM, Herranz MT, Delgado-Rodríguez M (March 1999). “The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body”. Br. J. Dermatol. 140 (3): 457–62. PMID 10233266.
↑ Echeverría B, Bulliard JL, Guillén C, Nagore E (January 2014). “Indicators for the total number of melanocytic naevi: an adjunct for screening campaigns. Observational study on 292 patients”. Br. J. Dermatol. 170 (1): 144–9. doi:10.1111/bjd.12692. PMID 24443914.

[pmid10233266-1] Fariñas-Alvarez C, Ródenas JM, Herranz MT, Delgado-Rodríguez M (March 1999). “The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body”. Br. J. Dermatol. 140 (3): 457–62. PMID 10233266.

[pmid24443914-2] Echeverría B, Bulliard JL, Guillén C, Nagore E (January 2014). “Indicators for the total number of melanocytic naevi: an adjunct for screening campaigns. Observational study on 292 patients”. Br. J. Dermatol. 170 (1): 144–9. doi:10.1111/bjd.12692. PMID 24443914.

[1]

[2]

Melanocytic nevus screening

Overview

Screening

References

Looking for the patient version?